Member Info for Globalcrossings

Based on the last 2 rns's..:)

LONDON (Dow Jones)--Invu PLC (INVU.LN), said Monday that it made pretax loss of Loss before tax of GBP4.5 million for the year ended Jan. 31, compared with GBP9.6 million. MAIN FACTS: -Revenue of GBP2.2 million versus GBP3.4 million -Sales through resellers to end users of GBP2.8 million versus GBP3.3 million -Loss from operations GBP4.36 million versus GBP9.60 million -Basic and diluted loss per share 3.24 pence versus 7.89 pence -Net Cash outflow from operating activities GBP2.7 million versus outflow GBP2.4 million -Increase in end user sites from 4,208 in FY 2009 to 4,505 in FY 2010 -The company is in a better position for the year ahead. Shares closed Friday at 1.05 pence. -By Razak Musah Baba, Dow Jones Newswires; +44-20-7842-9275; razak.baba@dowjones.com Order free Annual Report for INVU plc Visit http://djnweurope.ar.wilink.com/?ticker=GB00B28Y2K12 or call +44 (0)208 391 6028 (END) Dow Jones Newswires May 17, 2010 04:15 ET (08:15 GMT)

LONDON (Dow Jones)--Entertainment company Galleon Holdings PLC (GON.LN) Monday said its China subsidiary is one of 10 firms to qualify as a provider of international games and content for 3G handsets to China Mobile Ltd (CHL). Emerging markets-focused Galleon didn't provide financial details but said selected games and content from its China operation, Galleon China, will be marketed by China Mobile on an exclusive basis through methods like embedding in its handsets, web and WAP portals and direct marketing. The bulk of the content will be marketed on a non-exclusive basis by Galleon China and will be supported by Galleon mobile applications and games portal, run by Galleon's newly-formed online operation. Galleon Holdings Chief Executive Officer Stephen Green said the company views the next generation of smartphones in China as a "significant opportunity" for the company. China Mobile is the world's largest network operator with over 500 million subscribers. Galleon said smartphone penetration in China is expected to increase from 15.3% of the population in 2008 to 45% of the population by 2013. Company website: www.galleonplc.com -By Hannah Benjamin, Dow Jones Newswires; 44-20-7842-9298; hannah.benjamin@dowjones.com (END) Dow Jones Newswires May 17, 2010 04:16 ET (08:16 GMT)

LONDON (Dow Jones)--Surgical Innovations Group PLC (SUN.LN), a designer and manufacturer of innovative surgical devices, said Monday it has now delivered a GBP616,000 order, which was delayed as a consequence of third party technical difficulties, to one of its key industrial partners. MAIN FACTS: -This is the largest single order the Group has received within its industrial division. -Shares at 0810 GMT up 0.18 pence, or 4.7%, at 3.88 pence. -By Tommy Stubbington, Dow Jones Newswires; 44-20-7842-9268; tommy.stubbington@dowjones.com (END) Dow Jones Newswires May 17, 2010 04:10 ET (08:10 GMT)

Some nice movement with IFM today! GLA

GLA!:)

LONDON (Dow Jones)--London-based international film group Intandem Films PLC (IFM.LN) Monday announced it will co-produce and sell a new movie about the Iraq war which will star two-time Oscar winner Hilary S****. The movie, called 'Dreams of a Dying Heart', tells the story of a female helicopter pilot who is shot down in Iraq. Intandem said it brings its productions up to 31 films under management. It will co-produce and sell the movie with New York-based producer Killer Films and Los Angeles-based Laureate Films. Intandem Films didn't provide any financial details of the deal but said it looks forward to adding more films to its slate in 2010. Company Website: www.intandemfilms.com -By Hannah Benjamin, Dow Jones Newswires; 44-20-7842-9298; hannah.benjamin@dowjones.com (END) Dow Jones Newswires May 17, 2010 03:59 ET (07:59 GMT)

Again! 5p buy:) http://www.screencast.com/users/globalcrossings/folders/Jing/media/590e7b3a-37ac-4d77-a1e4-78dc0dfbfe7d

Myself a video.... http://www.youtube.com/watch?v=sHnXOSxka1Q

Thanks mate... I'm used to it as I get the same from Mrs. Global!:) lol

http://www.plusmarketsgroup.com/details.shtml?ISIN=GB0000617950/GBX/PLUS-exn Spread 4.62-5.0p:)

http://www.screencast.com/users/globalcrossings/folders/Jing/media/da2499c5-f2ae-449a-a54c-220c204019a9

Again!!!:)

Bid 4.50p Ask 5.50p :):):)

http://www.screencast.com/users/globalcrossings/folders/Jing/media/e468e770-e647-4be3-bb5b-a748e4cb50aa

Buys going through on the Plus Market.:)

I had a good gut feeling about AUK this morning!:) GLA

GLA

LONDON (Dow Jones)--Architecture and design company Aukett Fitzroy Robinson Group PLC (AUK.LN) said Monday it expects its first-half loss to narrow on year to just under GBP300,000. The expected loss for the six months to March 31 is down 75% compared with the GBP1.2 million loss the company posted in the same period a year earlier. Aukett also said that, having generated around GBP500,000 of cash in the first half, it has cut its net debt to under GBP1 million, down from GBP1.4 million at Sept. 30. The firm said that the GBP1.2 million due from recent successful litigation is still due to be collected. The timing of any collection is likely to be dependent on the sale of the U.K. properties on which the monies are secured, Aukett said. The company said it has secured a number of new projects in London, including the redevelopment of a residential and retail block in Covent Garden, and is currently bidding or working on a number of other significant sites in the city. It is also bidding on a number of hotel schemes. Company website: www.aukettfitzroyrobinson.com -By Rachael Gormley, Dow Jones Newswires; 44-20-7842-9308; rachael.gormley@dowjones.com (END) Dow Jones Newswires May 17, 2010 02:53 ET (06:53 GMT)

RNS Number : 0154M Osmetech PLC 17 May 2010    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM THE UNITED STATES OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. THIS ANNOUNCEMENT IS MADE IN ACCORDANCE WITH THE REQUIREMENTS OF THE AIM RULES FOR COMPANIES. Osmetech plc   Update regarding Scheme timetable, listing of GenMark on NASDAQ and GenMark Fundraising Following the approval of the Scheme and associated matters at the Osmetech Shareholder Meetings, the Board of Osmetech today provides the following update in relation to the Scheme timetable, listing of GenMark on NASDAQ and the GenMark Fundraising. On 13 May 2010, GenMark filed Amendment Number 2 ("Amendment") to its Registration Statement on Form S-1 originally filed with the United States Securities and Exchange Commission on March 19, 2010 (file no. 333-165562).  The Amendment includes an initial estimate of the price range (US $8.00 to US $10.00) at which the GenMark Shares are proposed to be issued in the GenMark Fundraising.  This price range is subject to further amendment and the GenMark Directors are permitted to issue the GenMark Fundraising Shares outside any published price range. As set out in the Scheme Document, if fully implemented, the Scheme will result in all Osmetech Shareholders becoming shareholders in GenMark, on the basis of one GenMark Share for every 230 Osmetech Shares held at the Scheme Record Time.  Using a US$/UK sterling exchange rate of 0.6843, being the exchange rate prevailing on 13 May 2010, the initial estimated price range equates to an estimated value of between 2.38 pence and 2.98 pence for each Osmetech Share in issue as at today's date. A copy of the Amendment may be viewed on the Securities and Exchange Commission website at www.sec.gov.  In view of the delay in the filing of the Amendment, the Court Hearing to sanction to the Scheme has been rescheduled to take place on 26 May 2010, which would delay the Effective Date of the Scheme to 1 June 2010 and the cancellation of trading on AIM to 2 June 2010.  The revised expected timetable is set out in the appendix to this announcement, although it is emphasised that the dates given are indicative only, and are subject to change. Terms defined in the Scheme Circular shall have the same meaning(s) when used in this announcement. Contacts For further information contact: Osmetech plc Steven Kemper, Chief Financial Officer - +1 626 463 2004 Jon Faiz Kayyem, Chief Executive Officer - +1 626 463 2000   Canaccord Genuity Limited (Nominated Advisor) 020 7050 6500 Robert Finlay Henry Fitzgerald-O'Connor   As of 10 May 2010, Canaccord Adams Limited, the Company's nominated adviser and broker has changed its name to Canaccord Genuity Limited.   THIS ANNOUNCEMENT IS NOT AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY S